Latest Regulatory News

Kore Potash has signed a landmark $1.929 billion fixed-price EPC contract for its Kola Potash Project, reinforcing its strategy to become a low-cost producer. The company is now awaiting a financing proposal from the Summit Consortium expected by February 2025.

Inca Minerals Limited reported steady progress in its December 2024 quarterly activities, focusing on refining exploration targets and securing funding while navigating regulatory and operational challenges.

Jameson Resources Limited has made significant progress in environmental approvals for its Crown Mountain Hard Coking Coal Project, while community and political backing for the coal sector in Canada strengthens. The company plans to resubmit its Environmental Impact Statement by mid-2025.

Atlantic Lithium has cleared critical regulatory hurdles for its Ewoyaa Lithium Project in Ghana, securing key permits and raising A$10 million to advance construction plans. The company also updated its feldspar resource estimate, underscoring the project's growing commercial potential.

Mako Gold Limited has agreed to a takeover by Aurum Resources, creating a stronger gold exploration entity in West Africa with over A$20 million in cash to accelerate development at key projects.

Magnum Mining and Exploration Limited moves forward with acquiring two promising rare earth element projects in Brazil while progressing negotiations on a green pig iron venture in Saudi Arabia.

Eclipse Metals Ltd reports significant progress in its Greenland rare earth projects, including access to historic drill cores and positive resource estimates, while advancing towards mining licenses and applying for EU strategic funding.

Beam Dental Bidco Pty Ltd has extended its off-market takeover offer for Pacific Smiles Group Limited, pushing the closing date to 11 February 2025. This move signals continued strategic interest and keeps the acquisition prospects open.

A1 Investments & Resources Ltd reports a modest cash outflow for the June 2024 quarter while actively pursuing acquisitions and planning convertible note funding to support growth.

Clara Resources outlines key progress on its Ashford Coking Coal Project drilling preparations and details ongoing capital management initiatives, including rights issues and entitlement offers, while navigating boardroom challenges.

Alterity Therapeutics has reported positive Phase 2 results for ATH434, showing significant slowing of Multiple System Atrophy progression and a favorable safety profile. The trial demonstrated clinical benefits alongside reductions in brain iron accumulation, a key disease driver.

Paradigm Biopharmaceuticals has secured FDA clearance for its phase 3 knee osteoarthritis trial and raised $16 million to fund its next clinical steps, positioning the company for a pivotal year ahead.